Market Place
Sourcing Support
Cyrano Therapeutics Secures $9.0 Million Series B Financing
16 Jan 2024 //
PR NEWSWIRE
Cyrano Therapeutics Enrolls First Patient in Phase 2 Trial of CYR-064
12 Oct 2023 //
PR NEWSWIRE
Cyrano to initiate Phase II trial of nasal spray therapy for Hyposmia
19 Jan 2023 //
CLINICAL TRIALS ARENA
Cyrano Appoints John Kollins to its Board of Directors
09 Nov 2021 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.